Capital International Sarl Seagen Inc. Transaction History

Capital International Sarl

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $6.02 Million - $6.8 Million	-31,456 Reduced 42.61%	42,362 $8.99 Million
Q2 2023 Aug 11, 2023	SELL	$187.64 - $206.25 $11.9 Million - $13 Million	-63,156 Reduced 46.11%	73,818 $14.2 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $6.23 Million - $9.92 Million	48,834 Added 55.41%	136,974 $27.7 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $1.82 Million - $2.16 Million	15,532 Added 21.39%	88,140 $11.3 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $2.44 Million - $3.25 Million	18,036 Added 33.05%	72,608 $9.94 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $6.02 Million - $9.93 Million	-55,356 Reduced 50.36%	54,572 $9.66 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $5.04 Million - $6.65 Million	42,112 Added 62.1%	109,928 $15.8 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $1.3 Million - $1.74 Million	9,124 Added 15.55%	67,816 $10.5 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $843,303 - $1.01 Million	-5,920 Reduced 9.16%	58,692 $9.97 Million
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $1.52 Million - $1.81 Million	-11,259 Reduced 14.84%	64,612 $10.2 Million
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $416,655 - $578,124	-3,030 Reduced 3.84%	75,871 $10.5 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $13 Million - $16.7 Million	78,901 New	78,901 $13.8 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

Stay updated on Capital International Sarl with notifications on news.